Snapshot

DOI:

Focused and accessible - a renewed EuroIntervention!

We hope your year has begun well and full of excitement! It certainly has for us at EuroIntervention where we’re still at the beginning of all the new graphic changes and scheduling we spoke about in the last issue. And here it is – the first of our new, leaner, and more timely Journals that you will be receiving every 2 weeks. What do you think? We’re interested in your reactions and comments, so don’t hesitate to contact us online.

And, as for this issue itself, here are the key topics you’ll find right now:

EuroIntervention state-of-the-art

In a state-of-the-art on coronary spasm and vasomotor dysfunction, Zachary S. Yaker, Claire E. Raphael and colleagues review the current understanding, pathophysiology and treatment approaches for this frequently underdiagnosed condition.

Transcatheter aortic valve replacement explant for failed balloon-expandable valves vs failed self-expanding valves

Is mortality in transcatheter aortic valve replacement (TAVR) explantation associated with the type of failed transcatheter heart valve? Syed Zaid, Gilbert H.L. Tang and colleagues compare the outcomes of balloon-expandable valves versus self-expanding valves TAVR explantation using the EXPLANT-TAVR registry. The authors evaluate endocarditis, paravalvular leakage, structural valve deterioration and patient-prosthesis mismatch as well as mortality associated with the explantation of each valve type.

Prolonged mechanical circulatory support in high-risk PCI

What happens when you put high-risk PCI patients on prolonged mechanical circulatory support? Sugi Min, Jeffrey W. Moses and colleagues discuss early recognition of high-risk PCI and how best to wean patients off mechanical circulatory support, including the use of right heart catheterisation.

Real-world management of aortic stenosis patients

In a unique study out of Denmark, Xi Wang, Ole De Backer and colleagues examine the confluence of guideline recommendations and Heart Team evaluations. Focusing on a region with nearly 3 million people where all aortic stenosis patients are channelled through one centre, the authors analyse the value of the Heart Team in this “real-world” practice setting.

Volume 20 Number 2
Jan 15, 2024
Volume 20 Number 2
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved